In agreement with our findings, Karusheva et al. (9) found that severe reduction (60%) of dietary BCAA intake over alternate weeks for 1 month led to a 17% decrease in fasting plasma BCAA concentrations and a 28% reduction in postprandial insulin concentrations in patients with obesity and T2DM (9). The gene discussed is INS; the disease is Obesity.